ArticleAntiviral research2022

Development of a cost-effective ovine antibody-based therapy against SARS-CoV-2 infection and contribution of antibodies specific to the spike subunit proteins.

Stephen Findlay-Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.